Surgical Heart Valve Repair and Replacement Devices

Heart valve disorders may be treated with medication to stabilize the underlying condition, or with minimally invasive or open surgery to repair or replace the valves; this report focuses on open surgical solutions for heart valve repair and replacement. In 2023, the global market for surgical heart valve management products totaled nearly $2.7bn, with the US accounting for more than half of sales.

Market drivers include the aging of the population and associated increase in heart valve disease, expanded regulatory approvals for some devices, reintervention following the recurrence of disease following valve repair, and high rates of endocarditis and rheumatic heart disease in developing countries. Limiters to this market include competition from minimally invasive techniques such as TAVR, limited pricing increases due to competitive pressures and restricted healthcare budgets, and the lack of major new product innovations that address the disadvantages of current products.

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for surgical heart valve repair and replacement products including percutaneous balloon valvuloplasty (PBV) products (balloon catheters, guiding catheters, guidewires, introducers/sheaths, and accessories), surgical heart valve repair products (annuloplasty rings and accessories), and surgical heart valve replacement products (mechanical and tissue-based valves). Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2023–28.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].

Related Medtech Insight articles:

• News We’re Watching: AHA Meeting In Philly; Surgeons Call For TAVR Caution; China Approves J&J's Monarch Robot
• News We’re Watching: SALSA Reintroduced, FDA Approves Abbott Valve, Metallic Implant Study
• Abbott Adds New Surgical Tissue Valves

Subscribe to Medtech Insight to view these articles and more!